Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

XSEC:002675 주식 보고서

시가총액: CN¥10.9b

Yantai Dongcheng Pharmaceutical GroupLtd 미래 성장

Future 기준 확인 3/6

Yantai Dongcheng Pharmaceutical GroupLtd is forecast to grow earnings and revenue by 45.9% and 13.1% per annum respectively. EPS is expected to grow by 45.8% per annum. Return on equity is forecast to be 7.6% in 3 years.

주요 정보

45.9%

수익 성장률

45.8%

EPS 성장률

Biotechs 수익 성장44.8%
매출 성장률13.1%
향후 자기자본 수익률7.6%
애널리스트 커버리지

Good

마지막 업데이트01 Nov 2024

최근 미래 성장 업데이트

업데이트 없음

Recent updates

수익 및 매출 성장 예측

XSEC:002675 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (CNY Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/20263,906424N/A7605
12/31/20253,452327N/A6646
12/31/20243,119258N/A6486
9/30/20242,85391-167362N/A
6/30/20242,911137-280247N/A
3/31/20243,072224-340204N/A
12/31/20233,276210-235277N/A
9/30/20233,42726335490N/A
6/30/20233,603323199664N/A
3/31/20233,554302467853N/A
1/1/20233,583307607997N/A
9/30/20223,858220415986N/A
6/30/20223,851165292833N/A
3/31/20223,902140295846N/A
1/1/20223,912152413944N/A
9/30/20213,637341445788N/A
6/30/20213,5993537021,023N/A
3/31/20213,596411333618N/A
12/31/20203,419418310573N/A
9/30/20203,395214339645N/A
6/30/20203,312196149443N/A
3/31/20203,172164508760N/A
12/31/20192,993155446696N/A
9/30/20192,877366335500N/A
6/30/20192,709347458577N/A
3/31/20192,467302305457N/A
12/31/20182,333280372493N/A
9/30/20182,098228458600N/A
6/30/20181,842212N/A444N/A
3/31/20181,679185N/A339N/A
12/31/20171,596173N/A209N/A
9/30/20171,511172N/A79N/A
6/30/20171,377149N/A106N/A
3/31/20171,245145N/A106N/A
12/31/20161,158131N/A196N/A
9/30/20161,014119N/A210N/A
6/30/201690395N/A109N/A
3/31/201685283N/A103N/A
12/31/201579590N/A67N/A
9/30/201572594N/A36N/A
6/30/201572499N/A40N/A
3/31/2015727103N/A-16N/A
12/31/2014751104N/A52N/A
9/30/201478699N/A2N/A
6/30/201478396N/A-10N/A
3/31/201478291N/A66N/A
12/31/2013775101N/A-21N/A

애널리스트 미래 성장 예측

수입 대 저축률: 002675's forecast earnings growth (45.9% per year) is above the savings rate (2.9%).

수익 vs 시장: 002675's earnings (45.9% per year) are forecast to grow faster than the CN market (25.8% per year).

고성장 수익: 002675's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: 002675's revenue (13.1% per year) is forecast to grow slower than the CN market (14% per year).

고성장 수익: 002675's revenue (13.1% per year) is forecast to grow slower than 20% per year.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 002675's Return on Equity is forecast to be low in 3 years time (7.6%).

성장 기업 발견

7D

1Y

7D

1Y

7D

1Y